Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
AXSM Transcript
Axsome Therapeutics, Inc. (AXSM) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Neutral6-8
Axsome Therapeutics, Inc. (AXSM) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Neutral5-12
Axsome Therapeutics, Inc. (AXSM) Q1 2026 Earnings Call Transcript
Positive5-4
The earnings call summary presents a strong financial performance with a 45% revenue increase and a reduced net loss. Additionally, there is a strategic expansion of the AUVELITY sales force and ongoing development in multiple therapeutic areas. Although some risks are noted in forward-looking statements, the overall sentiment is positive due to strong revenue growth and effective cost management. The market cap indicates a moderate reaction, likely leading to a stock price increase of 2% to 8%.
Axsome Therapeutics, Inc. (AXSM) Presents at The Citizens Life Sciences Conference 2026 Transcript
Neutral3-13
AXSM Slides
Axsome Q1 2026 slides: 57% revenue growth amid FDA approval milestone2026-05-04
Axsome Q4 2025 slides: revenue surges 66%, stock dips on expenses2026-02-23
Axsome Therapeutics Q3 2025 slides: Strong revenue growth amid pipeline expansion2025-11-03
Axsome Q2 2025 slides: revenue surges 72% YoY, pipeline advances on track2025-08-04
AXSM Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
